2+ signals participate in various cellular processes with spatial and temporal dynamics, among which, inositol 1,4,5-trisphosphate 
Introduction
The hematopoietic and cardiac progenitors are derived from a common origin, i.e. Flk1
+ (also known as Vegfr2) multipotent mesodermal cells (Shalaby et al., 1997; Fehling et al., 2003; Kouskoff et al., 2005; Kattman et al., 2006; Liu et al., 2012) . Fate choices towards these lineages require complex orchestration of spatiotemporal signals and intracellular responses (Kattman et al., 2011; Kim et al., 2013) . So far, the mechanisms governing the fate choice between hematopoietic and cardiac lineages are incompletely defined (Liu et al., 2012; Org et al., 2015) .
Signaling pathways, such as Hedgehog, BMP, Notch, and Wnt, have been reported to regulate the specification of hematopoietic lineages (Lee et al., 2008; Kim et al., 2013) . Etv2, also known as ER71, is one of the key modulators that specify the hematopoietic versus cardiac identity in mesodermal cells (Lee et al., 2008) . Loss of Etv2 results in embryonic lethality at embryonic day 9.5 (E9.5) with complete absence of vessels and blood cells (Lee et al., 2008) . In addition, enhanced cardiac differentiation is observed from Etv2 -/-mouse embryonic stem cells (mESCs) at the expense of hematopoietic lineages (Liu et al., 2012) . Although downstream targets of Etv2, such as Scl, Gata2, Pu.1, Lom2, Foxc2, Tie2, and miR-130a (Van Handel et al., 2012; Liu et al., 2015; Singh et al., 2015) , have been well documented, the upstream modulators of Etv2 are not yet fully clarified (Rasmussen et al., 2012; Yamamizu et al., 2012; Shi et al., 2015) . Ca 2+ signals play important roles in developmental processes,
activated T cells (NFAT). The balance of Ca

2+
-NFAT signaling in tissue progenitors is critical for normal embryonic development (Muller et al., 2009) . Recently, NFATc4 (also known as NFAT3) is proposed to regulate Etv2 expression (Koyano-Nakagawa et al., 2015) , indicating a possible involvement of Ca
-NFAT signals in mesodermal fate decision. Indeed, NFATc3 and NFATc4 pattern the developing vasculature, which is from the same origin as hematopoietic lineages in mouse embryos (Graef et al., 2001 ), but it is unknown whether NFATc3 and NFATc4 are involved in hematogenesis. Meanwhile, Ca
-NFAT signals are involved in heart development as well as pathological conditions, such as hypotrophy (Gomez et al., 2013; Mass et al., 2014) .
The endoplasmic reticulum (ER) serves as a major intracellular Ca 2+ store in mESCs and derived progenies (Yanagida et al., 2004; Fu et al., 2006) . Inositol 1,4,5-trisphosphate (IP 3 ) is an important messenger for Ca 2+ signals downstream of G proteincoupled receptors (GPCRs) and receptor tyrosine kinases (RTKs) (Mikoshiba, 2007) . IP 3 receptors (IP 3 Rs), encoded by three genes (Itpr1, Itpr2, and Itpr3), are one of the major Ca 2+ release channels on ER and play a principal role during the embryonic development before the expression of ryanodine receptors (RyRs), another type of Ca 2+ release channels located at ER (Mikoshiba, 2011) . Although the studies of individual IP 3 R subtypes in development and physiology have been benefited by gene knockout mouse models, further investigation of the whole IP 3 R family was hindered by embryonic lethality after genetic knockout of all three genes (Mikoshiba, 2011) . Recently, a conditional tripledeletion of the IP 3 R family (IP 3 R-tKO) was carried out in Tie2 + lineages, thus the roles of IP 3 Rs as a whole in T cell development and specification were revealed (Ouyang et al., 2014) .
In this study, we investigated the role of IP 3 Rs in early hematopoietic and cardiac fate decision by using IP 3 R-tKO mESCs. The IP 3 R-Ca 2+ -calcineurin-NFATc3 axis was found to be critical for the hematopoietic and cardiac lineage divergence through regulating Etv2 expression. These findings provide direct evidence supporting that IP 3 Rs-released Ca 2+ signals regulate mesodermal specification via the calcineurin-NFATc3-Etv2 pathway to orchestrate the divergence of hematopoietic and cardiac fate.
Results
IP 3 Rs are dispensable for the self-renewal of mESCs
The transcripts of all subtypes of IP 3 Rs (Itpr1-3) were detected in undifferentiated and differentiating mESCs, while they exhibited different expression patterns during differentiation ( Figure 1A ). The expression of Itpr1 transiently increased on differentiation day 3, the expression of Itpr2 continuously increased within the examined differentiation time, and the expression of Itpr3 transiently downregulated on differentiation day 2 ( Figure 1A) .
To investigate the requirement of IP 3 Rs in undifferentiated mESCs, we generated mESC lines with triple-knockout of all Itpr genes (Itpr1
, IP 3 R-tKO) through Cre-mediated recombination. Target loci were reported as previously described (Ouyang et al., 2014) . The gene inactivation in two clones (IP 3 R-tKO11 and IP 3 R-tKO12) was validated by the absence of loxP-flanked alleles ( Figure 1B ) and the lack of IP 3 Rs mRNA ( Figure 1C ) and protein ( Figure 1D ) expression. The transcripts of pluripotency markers Klf4, Oct4 (Pou5f1), Rex1 (Zfp42), and Sox2 q-PCR analysis of endogenous IP 3 R mRNAs in undifferentiated and differentiating cells (n = 4). (B) PCR analysis of the target loci of Itpr1-3 genes in the genome of control and IP 3 R-tKO mESCs. Sox2 locus was used as an internal control. (C) RT-PCR analysis of IP 3 R mRNAs in control and IP 3 R-tKO mESCs. 28s rRNA was used as an internal control. (D) Western blot analysis of IP 3 R proteins in control and IP 3 R-tKO mESCs. β-actin was used as an internal control. (E) Comparable expression level of pluripotency markers in control and IP 3 R-tKO mESCs (n = 4). (F) Similar percentages of SSEA1 + population between control and IP 3 R-tKO mESCs (n = 3). (G) ALP staining in control and IP 3 R-tKO mESCs. Scale bar, 100 μm. (H) Comparable expression of Oct4, Nanog, and SSEA1 in control and IP 3 R-tKO mESCs. Scale bar, 100 μm. (I) Identical doubling time of cell number in control and IP 3 RtKO mESCs (n = 4). n indicates the number of independent experiments. One-way ANOVA was used for E, F, and I.
were not significantly different between control (Itpr1 fl/fl 2 fl/fl 3 fl/fl ) and IP 3 R-tKO mESCs ( Figure 1E ). Flow cytometry (FACS) analysis showed comparable SSEA1 + population percentages in control and IP 3 R-tKO mESCs ( Figure 1F ). In addition, no significant differences were observed in alkaline phosphatase (ALP) activity between control and IP 3 R-tKO cells ( Figure 1G ). The immunofluorescence staining further confirmed the expression of pluripotent markers Oct4, Nanog, and SSEA1 in IP 3 R-tKO mESCs as well as in control cells ( Figure 1H ). The analysis of doubling time demonstrated comparable proliferation rates in control and IP 3 R-tKO mESCs ( Figure 1I ). Together, these data indicate that IP 3 Rs are dispensable in undifferentiated mESCs.
Loss of IP 3 Rs promotes the cardiac lineage commitment To identify whether IP 3 Rs regulate the cardiac differentiation of mESCs, control and IP 3 R-tKO mESCs were differentiated into spontaneously beating cardiomyocytes (Supplementary Video S1-S3) via forming embryoid bodies (EBs). Quantitative (q)-PCR analysis showed that control and IP 3 R-tKO mESCs displayed similar expression levels of ectodermal markers Fgf5 and Nestin, endodermal markers Foxa2 and Sox17, and early mesodermal markers T and Mesp1 (Figure 2A) . However, the mesodermal marker Flk1 was significantly lower in IP 3 R-tKO EBs than that in control EBs since differentiation day 4 (Figure 2A) . Conversely, early cardiac transcription factors Mef2c, Nkx2.5, and Tbx5, along with cardiomyocyte markers Myh6, Myl2, Myl7, and Tnnt2, were significantly enhanced during differentiation in IP 3 R-tKO cells (Figure 2A) . Consistently, FACS analysis further confirmed that α-myosin heavy chain (α-MHC + ) and cTnT + cells were increased in IP 3 R-tKO cells compared with control cells on differentiation day 7 ( Figure 2B ). In addition, the isolated cardiomyocytes from control and IP 3 R-tKO EBs displayed similar typical sarcomeric structure, as visualized by immunofluorescence of cTnT and α-actinin ( Figure 2C Figure 2D ) and several parameters of Ca 2+ transients, including the amplitude ( Figure 2E ) and time to peak ( Figure 2F ), 63% decay (T-63%, Figure 2G) , and 90% decay (T-90%, Figure 2H ), were all similar in control and IP 3 R-tKO cells.
Collectively, these data demonstrate that loss of IP 3 Rs promotes cardiac lineage specification, while it does not affect Ca
2+
homeostasis or Ca 2+ transients in ESC-derived cardiomyocytes.
Loss of IP 3 Rs impairs hematopoietic lineage differentiation Given the fact that Flk1 expression marks both hematoendothelial and cardiovascular mesoderm fates (Shalaby et al., 1997; Kattman et al., 2006) , the reduced expression of Flk1 but enhanced cardiac differentiation of IP 3 R-tKO mESCs suggested that Flk1
+ progenitor cell-derived hematopoietic lineage might be impaired in the absence of IP 3 Rs. The Flk1 + /PDGFRα − subpopulation is identified as hematopoietic mesoderm, while the Flk1 + /PDGFRα + subpopulation is considered as uncommitted and/or cardiac mesoderm (Kataoka et al., 2011; Kattman et al., 2011) . Our FACS analysis showed that the Flk1 + /PDGFRα − population markedly decreased in IP 3 R-tKO cells from differentiation day 3 to day 5, while the percentage of Flk1 + /PDGFRα + population was similar in control and IP 3 R-tKO cells ( Figure 3A) . The total Flk1 + population in IP 3 R-tKO cells decreased from day 4 to day 5 ( Figure 3A) . Consistently, gene expressions of hematopoietic markers Etv2, Gata1, Scl (Tal1), and Pu.1 (Spi1), as well as endothelial markers Tie2 (Tek) and CD31 (Pecam1), were significantly attenuated in IP 3 R-tKO cells ( Figure 3B) . Moreover, the production of CD41 + /c-Kit + hematopoietic progenitor cells (HPCs) on differentiation day 6 was significantly compromised in IP 3 R-tKO cells ( Figure 3C ). Colony-forming units (CFU) assay was also performed to measure both hematopoietic progenitor types and numbers. Numbers of erythroid cells (E), granulocytes/monocytes (G/M/GM), and granulocytes/erythroids/ myeloid-megakaryocytes (GEMM) were significantly reduced in IP 3 R-tKO cells compared with control cells ( Figure 3D ). These data suggest that IP 3 Rs are necessary for the emergence of hematopoietic mesoderm from Flk1 + progenitor cells. (Sun et al., 1999) , while none of IP 3 R-tKO cells showed such responses to serum ( Figure 4C ) and <5% of IP 3 R-tKO cells responded to ATP ( Figure 4D ). (Stachecki and Armant, 1996) , for 6 h on differentiation day 2, day 3, day 4, or day 5. FACS analysis showed that the addition of ionomycin on day 2 or day 4 promoted the production of c-Kit + /CD41 + HPCs in control cells by 1-fold ( Figure 4E ). The defects in HPC production of IP 3 R-tKO cells were rescued by addition of ionomycin on day 2, day 3, or day 4 but not on day 5 ( Figure 4E ). Furthermore, the yield of cTnT ] i (D), amplitude (E), time to peak (F), the time to 63% decay (G), and time to 90% decay (H) of the maximum amplitude in control and IP 3 R-tKO cells (n = 31 cells of control, n = 33 cells of IP 3 R-tKO11, and n = 30 cells of IP 3 R-tKO12 from three independent experiments). Repeated ANOVA was used for A; one-way ANOVA with Dunnett's multiple comparisons test was used for B; and one-way ANOVA was used for D-H. 
Loss of IP
IP 3 R-Ca
2+
-calcineurin signaling pathway is essential for the hematopoietic mesoderm commitment Next, we examined the possible involvement of calcineurin pathway in IP 3 R-Ca
-regulated hematopoietic differentiation. Cellular calcineurin activity assay showed that the endogenous calcineurin activity was significantly reduced in IP 3 R-tKO cells ( Figure 5A ). Consistent with the enhanced HPC production ( Figure 4E ), ionomycin treatment on day 3 promoted the percentage of Flk1
but not in control cells, which was abolished by pre-incubation of the calcineurin-specific inhibitors cyclosporine A (CsA) and FK506 (Clipstone and Crabtree, 1992 ) ( Figure 5B ). Figure S1 ). The production of CD41 + / c-Kit + HPCs showed similar results in these cells ( Figure 5C ).
Notably, the decrease in proportions of hematopoietic mesoderm and HPCs in control cells was also observed in the presence of CsA or FK506 together with ionomycin ( Figure 5B and C), suggesting that the endogenous calcineurin might be required for hematogenesis. To determine whether the endogenous calcineurin rather than a stress-induced response by ionomycin was required for early hematopoietic differentiation, we treated control cells with CsA or FK506 alone. Both of them significantly decreased the proportion of Flk1 Figure 5D ). To determine the time window in which calcineurin takes effect, we systematically added CsA or FK506 during differentiation days 2-6, individually or throughout, and then examined the percentage of CD41 + /c-Kit + HPCs on day 6 ( Figure 5E ). Blocking calcineurin activity on differentiation day 2 or day 3 significantly decreased the HPC production as the treatment during days 2-6 or days 3-6 ( Figure 5E ). This reveals an important role of calcineurin in mesodermal cell fate decision as early as on day 2. Further, we overexpressed the wild-type (wt) calcineurin A (CnA) and its deletion mutation △CnA, the constitutively active form of calcineurin (Shibasaki et al., 1996) , in control and IP 3 R-tKO mESCs. Reinforced expression of wt CnA had no effect on hematopoietic or cardiac lineage specification in both control and IP 3 RtKO mESCs, whereas the overexpression of △CnA enhanced the production of Flk1 Figure 5F ) but not Flk1 Figure S2) mesoderm. Moreover, the overexpression of △CnA increased the percentage of CD41 Figure 5G ) and the total CFU activity ( Figure 5H ) in both cell types. Consistently, the yield of cTnT + cardiomyocytes was reduced in both △CnA-expressing control and IP 3 R-tKO cells ( Figure 5I ). These results indicate that Ca
-regulated calcineurin activity is critical in the transition of mesoderm into early stage of hematopoietic and cardiac fate divergence.
-calcineurin signaling pathway activates Etv2 expression The alterations of differentiation in IP 3 R-tKO mESCs were reminiscent of those in mESCs or embryos with Etv2 mutations (Liu et al., 2012) . To test whether Etv2 is a target of IP 3 R-Ca 2+ -calcineurin signaling pathway, control and IP 3 R-tKO cells were exposed to ionomycin on differentiation day 2, day 3, or day 4 with or without calcineurin inhibitors. q-PCR analysis showed that the expression of Etv2 displayed a temporal pattern in 
Attenuated expression of hematopoietic genes Etv2, Gata1, Scl, Pu.1 and endothelial genes Tie2 and CD31 (n = 3). * P < 0.05 for IP 3 R-tKO-11 and # P < 0.05 for IP 3 R-tKO-12 compared with the corresponding control group. (C) Decreased c-Kit
+ HPCs in IP 3 R-tKO cells on differentiation day 6 (n = 3). (D) Reduced CFU competence in IP 3 R-tKO cells (left panel, n = 3) and the representative colony morphologies of control cells (right panel). Scale bar, 100 μm. n indicates the number of independent experiments. Two-way ANOVA with Dunnett's or Sidak's multiple comparisons test was used for A and D; repeated ANOVA was used for B; and one-way ANOVA with Dunnett's multiple comparisons test was used for C. -responding cells control cells. It stayed at low level on day 2 but significantly increased within one day and decreased on day 4 ( Figure 6A ). However, this transient expression pattern was not detected in IP 3 R-tKO cells ( Figure 6A ). Ionomycin treatment on day 2 significantly enhanced the expression of Etv2 in control and IP 3 R-tKO cells, which was abolished by concomitant treatment of the calcineurin inhibitor CsA or FK506 ( Figure 6A) . Addition of ionomycin on day 3 increased Etv2 expression in IP 3 R-tKO cells to a comparable level in control cells but did not affect Etv2 expression in control cells ( Figure 6A) . CsA or FK506 attenuated Etv2 expression in both control and IP 3 R-tKO cells in the presence of ionomycin on day 3 ( Figure 6A ). Ionomycin on day 4 had much less effect on Etv2 expression, only promoting it in control cells ( Figure 6A ). In contrast, overexpression of △CnA enhanced the expression of Etv2 in both control and IP 3 R-tKO cells from undifferentiated status to differentiation day 4 ( Figure 6B ), indicating that the Ca
-calcineurin signaling pathway serves as a sufficient regulator of Etv2 expression.
Bioinformatics analysis was performed to predict possible Ca 2+ -responsive elements within the Etv2 promoter. Five evolutionarily conserved regions (ECR1-5) harbored in the 3.6-kb promoter upstream of the Etv2 transcription start site were highly conserved among mouse, chimpanzee, and human but not in zebrafish ( Figure 6C) . It has been shown that the expression of reporter genes was almost lost when deleting the proximal 1-kb promoter (ECR1-2) of Etv2 (Koyano-Nakagawa et al., 2015), suggesting that this region is essential for the promoter activity of Etv2. We then generated constructs containing ECR1 and/or ECR2 regions upstream of the luciferase (luc) gene ( Figure 6D ). The promoter activity of ECR1 was higher than that of ECR2 but comparable to that of ECR1 + ECR2 in DMSO control ( Figure 6E) . Similarly, the promoter activities of ECR1 and ECR1 + ECR2 but not ECR2 were significantly enhanced by ionomycin treatment ( Figure 6E ) or △CnA overexpression ( Figure 6F ) in control cells on differentiation day 2. Next, we generated four truncated constructs of ECR1, based on the transcription factor binding site (TFBS)-rich motifs predicted by multiTF program ( Figure 6G ). Basal promoter activities of all truncated constructs were largely reduced compared with ECR1. Ionomycin treatment and △CnA overexpression still increased activity in ECR1-1, but not in ECR1-2, ECR1-3, or ECR1-4 ( Figure 6H and I). These results indicate that the second TFBS motif (in −334 to −375 bp of ECR1) may contain Ca 2+ signal-responsive elements. Bioinformatics analysis suggested that putative CREB, NFAT, and NFκB binding sites could locate in this region and that the NFAT-binding site GGAAAA (Badran et al., 2002 ) might be completely embedded in the NFκB-binding site GGRRNNYYCC (Nijnik et al., 2003) ( Figure 6J ). We thus made point mutations according to the TFBS sequences ( Figure 6J ). The mutation of the CREB motif (ECR1 mut1) attenuated basal promoter activity but retained Ca
-regulated activity by ionomycin ( Figure 6K ) and △CnA ( Figure 6L ). In contrast, the mutation of highly connected NFAT and NFκB binding sites (ECR1 mut2) did not affect basal promoter activity but abolished activitypromoting effect of ionomycin or △CnA ( Figure 6K and L) . Thus, the putative NFAT and NFκB binding sites within the proximal evolutionarily conserved region of Etv2 promoter are essential for Ca 2+ signal-regulated Etv2 gene expression.
NFATc3 directly targets the Etv2 promoter and rescues IP 3 R-tKO phenotype To further determine whether NFκB or NFAT regulates Etv2 expression, we performed chromatin immunoprecipitation (ChIP)-PCR assay during the differentiation of control and IP 3 R-tKO mESCs. The endogenous binding of NFATc3, but not CREB, NFκB, or other NFAT members, on the ECR1 region of Etv2 promoter was detected in control but not in IP 3 R-tKO cells ( Figure 7A ). The specificity of this binding was verified by short hairpin (sh)RNA against NFATc3 (Supplementary Figure S3A and B). Furthermore, we found that ECR1 but not ECR2 drove luc expression when co-expressing the constitutively active form of NFATc3 (CA-NFATc3, Figure 7B ). ECR1-2, ECR1-3, and ECR1-4 lost such responses to CA-NFATc3 ( Figure 7C ). Besides, both ECR1 mut2 and ECR1-1 mut2 dismissed CA-NFATc3-induced elevation of promoter activity ( Figure 7D ). In addition, bioinformatics analysis suggested that ECR5 contained a putative NFATbinding site as well. This was confirmed by the ChIP-PCR assay showing the binding of NFATc3 as well as CREB on the ECR5 in control cells but not in IP 3 R-tKO cells ( Figure 7E ). By using western blot, we demonstrated that cytosolic expression of NFATc3 was comparable in control and IP 3 R-tKO cells on differentiation day 3, but its nuclear expression was significantly reduced in IP 3 R-tKO cells (Supplementary Figure S4) . To dissect whether NFATc3 is sufficient to regulate the hematopoietic versus cardiac cell fate commitment, we overexpressed wt NFATc3 and CANFATc3 in control and IP 3 R-tKO mESCs. The expression of Etv2 was significantly enhanced by overexpression of CA-NFATc3 but not wt NFATc3 at 24 h after transfection ( Figure 7F) . Consistently, FACS analysis showed that percentages of Flk1 + /PDGFRα -population ( Figure 7G ), but not Flk1 Figure S5) , were increased in CA-NFATc3-overexpressing control and IP 3 R-tKO cells. Moreover, overexpression of CA-NFATc3 but not wt NFATc3 led to a significant increase of HPC production ( Figure 7H ) and CFUs ( Figure 7I ). The enhanced hematopoietic lineage specification was concurrent with the reduced cTnT + cardiomyocytes ( Figure 7J ). To clarify the essential role of NFATc3 for Etv2 expression, we transfected specific decreased in IP 3 R-tKO cells on day 3 (n = 3, each with 50-100 cells). Green signals are the fluorescent signals from the Ca 2+ indicator Fluo4. Scale bar, 25 μm. (E and F) Enhancement/rescue of HPC (E) and inhibition/recover of cardiomyocyte (F) productions in control or IP 3 R-tKO cells, respectively, with time-dependent ionomycin (1 μM) treatment during differentiation (n = 3). n indicates the number of independent experiments. Student's t-test was used for A-D and two-way ANOVA with Dunnett's multiple comparisons test was used for E and F.
* P < 0.05, *** P < 0.001 compared with the corresponding control or DMSO group.
small interference (si)RNAs against NFATc3 (si-NFATc3) into control mESCs and detected the expression of Etv2 after 24 h. The expression of NFATc3 was similar between the negative control siRNA (si-NC) and untreated control cells, while all three si-NFATc3 sequences significantly reduced NFATc3 transcripts in DMSO control or ionomycin-treated cells ( Figure 7K ). The Etv2 expression n indicates the number of independent experiments. Student's t-test was used for A; two-way ANOVA with Dunnett's or Sidak's multiple comparisons test was used for B, C, F-I; and one-way ANOVA with Dunnett's multiple comparisons test was used for D and E. * P < 0.05, ** P < 0.01, *** P < 0.001 compared with the corresponding DMSO or vehicle group. Figure 7L ). But such effect was abolished by knockdown of NFATc3 ( Figure 7L ). These data indicate that the IP 3 R-Ca 2+ -calcineurin-NFATc3 signaling pathway oppositely directs the hematopoietic and cardiac lineage commitment via targeting Etv2.
Discussion
The main findings of the present study are (i) IP 3 Rs are dispensable for the self-renewal of mESCs; (ii) IP 3 Rs play critical roles in hematopoietic versus cardiac mesoderm fate decision; (iii) (Kapur et al., 2007) , we do not find any significant changes in doubling time of IP 3 R-tKO mESCs, which is consistent with our previous finding that IP 3 R3-deficient mESCs have normal self-renewal capacity (Liang et al., 2010) . These observations are further supported by the in vivo data that embryos of Itpr1 Etv2 expression is tightly controlled by its threshold as reported recently (Koyano-Nakagawa et al., 2015) . Another important finding here is the discovery of downstream target of IP 3 R-Ca 2+ -regulated hematopoietic and cardiac fate divergence. Nkx2.5, Ovol2, Gata2, Mesp1, and Creb1 have been reported as regulators of Etv2 (Ferdous et al., 2009; Kim et al., 2014; Shi et al., 2014 Shi et al., , 2015 . These studies mainly focus on the transactivator or coactivator of Etv2, while little is known about the upstream signaling. Our data here demonstrate that Etv2 expression is highly regulated by the IP 3 R-Ca 2+ -calcineurin signaling pathway. This is supported by the recent observation that the Flk1-calcineurin cascade modulates the promoter activity of Etv2 by reporter assays (Koyano-Nakagawa et al., 2015) , while our data further identify that the IP 3 Rs-mediated Ca 2+ is a critical upstream regulator of this pathway, and it subsequently controls Etv2-regulated hematopoietic and cardiac fate commitment. In addition, the involvement of NFAT family members in hematopoietic and cardiac fate commitment via the IP 3 Rs-mediated Ca 2+ -calcineurin signaling pathway is identified here. Although the calcineurin antagonist CsA has been recognized to enhance cardiac differentiation in mESCs and embryonic carcinoma cells (Yan et al., 2009; Choi et al., 2015) , the underlying mechanisms are not fully understood. We show that the treatment of CsA or FK506 is sufficient to block hematopoietic differentiation in control mESCs and to abolish the Ca 2+ ionophore ionomycinmediated rescue in IP 3 R-tKO cells. In contrast, overexpression of △CnA enhances hematopoietic mesoderm and HPCs whereas largely attenuates the cTnT + cardiomyocytes in differentiating mESCs, though its effects on gene expression of different lineages remain to be future studied. Moreover, we reveal that the endogenous NFATc3, but not NFATc1, NFATc2, NFATc4, or NFκB, binds to the promoter of Etv2 as the downstream mediator of the IP 3 R-Ca
2+
-calcineurin signaling pathway. This differs from the observation that NFATc4 binds to the Etv2 promoter (Koyano-Nakagawa et al., 2015) . The difference may be attributed to the various peak time of endogenous Etv2 expression between different cell lines. In addition, functional redundancy has also been shown to exist between NFATc3 and NFATc4 (Graef et al., 2001) , suggesting different NFAT subtypes might contribute in the same process. Furthermore, we determine the NFAT-binding site within ECR1 as a Ca 2+ -responsive element.
Taken together, we not only confirm the recent finding that calcineurin-NFAT pathway regulates Etv2 promoter activity (Koyano-Nakagawa et al., 2015) , but also identify the critical role of another NFAT member (NFATc3) in the regulation of hematopoietic and cardiac fate commitment as well as its downstream target Etv2 and the binding site on the Etv2 promoter. It will be interesting to study the nuclear localization of NFATc3 in and putative binding sites for CREB, NFAT, and NFκB. The point mutants of CREB (mut1) and NFAT/NFκB (mut2) sites are shown. R, purine; N, any nucleotide; Y, pyrimidine. (K and L) ECR1 mut2 but not ECR1 mut1 lost transcriptional response to ionomycin (1 μM) (K) or △CnA (L) (n = 3). n indicates the number of independent experiments. Two-way ANOVA with Dunnett's multiple comparisons test was used for A, B, E, and F and Student's t-test was used for H, I, K, and L. to regulate mesodermal fate choices with similar outcomes: the suppressed Cdx expression inhibited hematopoiesis and enhanced cardiac differentiation (Lengerke et al., 2011) . A possible correlation might exist between the Ca 2+ -calcineurinNFATc3 and Cdx-Hox axis pathways, as Cdx2 could regulate Flk1 expression (Ishitobi et al., 2011) . Ligand-activated Ca 2+ signals have been found playing a role in human ESC (hESC) self-renewal (Apati et al., 2012) and their neuronal differentiation (Malmersjo et al., 2010) . Recently, we found a distinct regulatory pathway for Ca 2+ signals in hESCs and derived cardiovascular progenitor cells (Huang et al., 2016) . It is of great interest to test whether the IP 3 R-Ca 2+ -calcineurinNFATc3-Etv2 pathway identified here regulates hESC hematopoietic and cardiac fate divergence, even in vivo if applicable, in future work.
In conclusion, we find that IP 3 Rs are crucial for the hematopoietic versus cardiac fate decision of mESCs through the activation of Ca 2+ -calcineurin-NFATc3 cascade via targeting Etv2
( Figure 8 ). Our findings provide new insights into the role of IP 3 Rsmediated Ca 2+ signals in specific lineage fate decision during early ESC differentiation and mesoderm-derivative selection.
Materials and methods
Generation of IP 3 R-tKO mESCs and cellular analysis mESC lines were established from the Itpr1 fl/fl 2 fl/fl 3 fl/fl mice (Ouyang et al., 2014) based on the method previously described (Liu et al., 2014) . Briefly, Itpr1 fl/fl 2 fl/fl 3 fl/fl mESCs were transiently transfected with an expression vector containing Cre recombinase by Lipofectamine 2000 (Invitrogen). The genomic DNA of IP 3 R-tKO cells was extracted and subsequently subjected to PCR amplification to verify the absence of target sequences. The detection sequences are illustrated in Supplementary Figure S6 , and the primer sequences are listed in Supplementary Table S1 . Itpr1 fl/fl 2 fl/fl 3 fl/fl mESCs transiently transfected with vehicle vector were used as control mESCs.
mESC culture and in vitro differentiation
The mESCs were routinely maintained on mitomycin C-treated mouse embryonic fibroblast (MEF) cells in the presence of LIF (Millipore, 1000 U/ml) as previously described (Liang et al., 2010) . The hematopoietic and cardiac differentiation of mESCs was initiated by using the hanging drop method without LIF and MEF as previous described (Kim et al., 2013) .
Reverse transcription (RT)-PCR and q-PCR
The RNA was prepared using Trizol (Invitrogen) and analyzed by RT-PCR and q-PCR as previously described (Cao et al., 2011) . The RT-PCR primers are listed in Supplementary Table S2 , and the qRT-PCR primers are listed in Supplementary Table S3 .
Western blot analysis
Whole-cell proteins extracted from mESCs were conducted for western blot analysis as previously described (Liang et al., 2010) . Cytosolic and nuclear fractions were isolated with Minute™ cytoplasmic & nuclear extraction kits (Invent, SC-003) according to the manual. Blots were incubated with the primary antibodies against IP 3 R1 (1:1000) (Ouyang et al., 2014) , IP 3 R2 (1:1000) (Ouyang et al., 2014) , IP 3 R3 (1:1000, BD Biosciences), β-actin (1:4000, Sigma), NFATc3 (1:400, Santa Cruze), β-tublin (1:1000, Santa Cruze), and histone H3 (1:1000, Cell Signaling Technology). IRDye 680LT donkey anti-rabbit IgG or IRDye 800LT donkey anti-mouse IgG (1:4000, Li-COR Biosciences) were used as secondary antibodies. The immunoreaction was visualized on an Odyssey Infrared Imager (Li-COR).
FACS analysis
Undifferentiated mESCs or EBs were trypsinized and stained for the presence of appropriate membrane markers, including PE-Cy5. Immunocytochemical staining ALP activities were detected by staining with ALP substrate kit III (Vector Laboratories, SK-5300) according to the manual. Immunofluorescence assays were performed according to the protocol described before (Wang et al., 2012) . Cells were stained with primary antibodies against Oct4 (1:100, abcam), Nanog (1:100, abcam), SSEA1 (1:200, eBioscience), cTnT (1:300, Abcam), and α-actinin (1:200, Sigma) and detected by DyLight 488-or DyLight 549-conjugated secondary antibody (Jackson ImmunoResearch). Nuclei were stained with DAPI (1:2000, Sigma). Cells were imaged by a Zeiss Observer fluorescence microscope. ) from whole EBs on differentiation day 6 were plated on a 35-mm ultra-low attachment culture dish with 1.5 ml of MethoCult (M3434, Stem Cell Technologies) according to the manufacturer's instructions. Hematopoietic colonies were scored based on the morphology at 7-10 days after plating. These assays were performed in duplicate and independently repeated for three times.
Cellular calcineurin activity assay
Cells from day 3 EBs were dissociated. The cell extracts were prepared using reagents provided in the calcineurin cellular activity assay kit (BML-AK816-0001, Enzo Life Sciences). The assay was performed following manual's instructions. The absorbance values from the assay were converted into amount of released phosphate according to manual's instructions.
Bioinformatics analysis
Evolutionarily conserved regions of mammalian Etv2 were identified with ECR Browser (http://ecrbrowser.dcode.org/) (Ovcharenko et al., 2004) aligned by Mulan (http://mulan. dcode.org/) (Loots and Ovcharenko, 2007) and searched for conserved motifs by multiTF within the ECR Brower.
Dual luciferase report assay
Cells in 48-well plates were transfected with 200 ng of luciferase reporters, with or without 200 ng △CnA or CA-NFATc3 expressing plasmids, in each well by using lipofectamine 2000. Renilla luciferase reporter vector pRL-TK (30 ng, Promega) was also included as the internal control. For detection of Ca
2+
-induced reporter activity, ionomycin or DMSO treatment was performed for 3 h before the collection of samples. Lysates were harvested 24 h after transfection, and the reporter activity was measured with the Dual Luciferase Assay (Promega) according to the standard protocol.
ChIP assay
ChIP assay was performed using a Simple ChIP™ Enzymatic Chromatin IP Kit (9002, Cell Signaling Technology) according to the manual. Protein-DNA complex was immunoprecipitated with antibodies against CREB (Cell Signaling Technology), NFATc1 (Abcam), NFATc2 (Abcam), NFATc3 (Santa Cruze), NFATc4 (Santa Cruze), NFκB (Cell Signaling Technology), and normal rabbit IgG (Cell Signaling Technology). The purified DNA was quantified by q-PCR to detect the enrichment of Etv2 proximal promoter (forward: 5′-AGTTCAGACACCCAGGCATT-3′; reverse: 5′-CATCCCTGC AACTTGACCCAG-3′) and distal promoter (forward: 5′-CAGGGGGC TAAAGGGCATT-3′; reverse: 5′-GGTGACTTTGGAGAGGTGTCAA-3′) by normalized to the total input control.
Cell transfection of siRNA and shRNA si-NC and si-NFATc3 were synthesized by Gene Pharma (si-NC, 5′-UUCUCCGAACGUGUCACGUTT-3′; si-NFATc3-1, 5′-GGAUCUCAG UAUCCUUUAATT-3′; siNFATc3-2, 5′-CUGCAAGUCAAGAGAUAAU TT-3′; siNFATc3-3, 5′-GAGGCCACGAAAUGAUUGUTT-3′). si-NFATc3 and si-NC were transfected into mESCs using DharmaFECT1 (Thermo-fisher) according to the manufacturer's instructions.
Two 21-bp sequences shNC (5′-TTCTCCGAACGTGTCACGTTT-3′) and shNFATc3 (5′-CTGCAAGTCAAGAGATAATTT-3′) were cloned into the pLKO1 vector containing puromycin-resistant gene. The control mESCs were transfected with the shNC and shNFATc3 plasmids by electroporation. After selection by puromycin (Life Technologies) at 1 mg/ml, single clones were picked out and amplified.
Statistical analysis
Data were presented as mean ± SEM. Statistical analyses were performed using one-way ANOVA, two-way ANOVA, or student's t-test as appropriate with GraphPad Prism 6. P < 0.05 was considered statistically significant.
Supplementary material
Supplementary material is available at Journal of Molecular Cell Biology online.
